Risk of Intestinal Malignancy in Patients With Short Bowel Syndrome.

about

Risk of Intestinal Malignancy in Patients With Short Bowel Syndrome.

Item

http://www.wikidata.org/entity/Q53327324

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Risk of Intestinal Malignancy in Patients With Short Bowel Syndrome.

@en

Risk of Intestinal Malignancy in Patients With Short Bowel Syndrome.

@nl

type

Item

label

Risk of Intestinal Malignancy in Patients With Short Bowel Syndrome.

@en

Risk of Intestinal Malignancy in Patients With Short Bowel Syndrome.

@nl

prefLabel

Risk of Intestinal Malignancy in Patients With Short Bowel Syndrome.

@en

Risk of Intestinal Malignancy in Patients With Short Bowel Syndrome.

@nl

P1476

Risk of Intestinal Malignancy in Patients With Short Bowel Syndrome.

@en

P2093

Alan N Langnas

http://www.w3.org/2001/XMLSchema#string

David F Mercer

http://www.w3.org/2001/XMLSchema#string

Fedja A Rochling

http://www.w3.org/2001/XMLSchema#string

Jon S Thompson

http://www.w3.org/2001/XMLSchema#string

Luciano M Vargas

http://www.w3.org/2001/XMLSchema#string

Rebecca A Weseman

http://www.w3.org/2001/XMLSchema#string

Wendy J Grant

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular origins of cancer: Molecular basis of colorectal cancer

Chronically administered retinoic acid has trophic effects in the rat small intestine and promotes adaptation in a resection model of short bowel syndrome

Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis.

AGA technical review on short bowel syndrome and intestinal transplantation.

Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008.

Side effects of long-term glutamine supplementation.

Self-renewal and cancer of the gut: two sides of a coin.

Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?

GLP1 and cancer: friend or foe?

Outcomes of colorectal cancer arising in solid organ transplant recipients.

P304

562-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0148607115609587

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26419925

http://www.w3.org/2001/XMLSchema#string